Tigers' Magglio Ordonez notches 2,000th career hit

1 Comment

magglio ordonez swinging.jpgWith a single off Carl Pavano on Thursday, Magglio Ordonez because the 19th active major leaguer and the sixth native of Venezuela to reach 2,000 career hits.
The active list:
1. Ken Griffey Jr. – 2,775
2. Derek Jeter – 2,773
3. Ivan Rodriguez – 2,735
4. Omar Vizquel – 2,706
5. Alex Rodriguez – 2,551
6. Manny Ramirez – 2,511
7. Garret Anderson – 2,506
8. Johnny Damon – 2,450
9. Chipper Jones – 2,420
10. Vladimir Guerrero – 2,277
11. Edgar Renteria – 2,209
12. Todd Helton – 2,153
13. Jim Thome – 2,149
14. Bobby Abreu – 2,139
15. Miguel Tejada – 2,133
16. Jason Kendall – 2,106
17. Ichiro Suzuki – 2,060
18. Mark Grudzielanek – 2,017
19. Magglio Ordonez – 2,001
The only other player with much chance of reaching the plateau this year is Jim Edmonds, who is currently at 1,898. Luis Castillo (1,848), Orlando Cabrera (1,837), Carlos Lee (1,831), Scott Rolen (1,826) and Albert Pujols (1,745) should all get there in 2011.
At age 36, Ordonez is quite a long shot to reach 3,000 career hits. However, both he and Abreu do have a chance of overtaking Vizquel to become the all-time hits leader from Venezuela:
1. Omar Vizquel – 2,706
2. Luis Aparicio – 2,677
3. Andres Galarraga – 2,333
4. Dave Concepcion – 2,326
5. Bobby Abreu – 2,136
6. Magglio Ordonez – 2,001
7. Ozzie Guillen – 1,764
8. Manny Trillo – 1,562
9. Cesar Tovar – 1,546
10. Edgardo Alfonzo – 1,532
Ordonez also had a shot at reaching 300 homers this year, as he’s currently 19 away. At 399, Galarraga is the all-time home run leader from Venezuela. Ordonez is second place on that list, though his Tigers teammate Miguel Cabrera is at 214 and charging fast.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.